EPCAM and colorectal carcinoma: In 1995, the anti-EpCAM mAb reported by Herlyn et al. was the first ever approved for the treatment of oncologic patients (1995, Germany) under the name edrecolomab, although it was subsequently withdrawn when larger studies showed no benefit compared with standard chemotherapy in CRC [88].